Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorthalidone vs Hydrochlorothiazide in Hypertension
NCT01748123Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Aug 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorthalidone in hypertension (HTN), sponsored by Johns Hopkins University. Planned start Aug 2016; status: withdrawn.
02
Drugs
chlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01748123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748123.